Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
18.1M
-
Shares change
-
+723K
-
Total reported value, excl. options
-
$13M
-
Value change
-
+$520K
-
Number of buys
-
14
-
Number of sells
-
-16
-
Price
-
$0.72
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2025
55 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q3 2025.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.1M shares
of 43.4M outstanding shares and own 41.6% of the company stock.
Largest 10 shareholders include Bleichroeder LP (6.82M shares), GC Wealth Management RIA, LLC (3.43M shares), VANGUARD GROUP INC (3.04M shares), GEODE CAPITAL MANAGEMENT, LLC (801K shares), BOOTHBAY FUND MANAGEMENT, LLC (611K shares), Robertson Stephens Wealth Management, LLC (479K shares), BlackRock, Inc. (449K shares), BANK OF AMERICA CORP /DE/ (325K shares), ADVISORY RESEARCH INC (257K shares), and RENAISSANCE TECHNOLOGIES LLC (227K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.